Nkgen Biotech Inc (NKGN)

$0.26 +0.07 (35.91%)
Market Cap 8.60M
Revenue (ttm) 0.00
Net Income (ttm) -82.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.10
Volume 1,562,500
Avg Vol 4,676,562
Day's Range N/A - N/A
Shares Out 44.95M
Stochastic %K 0%
Beta 0.45
Analysts Strong Buy
Price Target N/A

Company Profile

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells. Its lead products include SNK01, an autologous NK cell therapy candidate for the treatment of neurodegenerative diseases, and SNK02, an allogeneic NK cell therapy for refractory solid tumors. The company has a license agreement with NKMAX for its NK cell program. The company was formerly known as NKMAX America, Inc. NKGe...

Industry: Biotechnology
Sector: Healthcare
Phone: 949-396-6830
Address:
3001 Daimler Street, Santa Ana, United States
RupertDCat
RupertDCat Jul. 11 at 2:29 AM
$NKGN https://finance.yahoo.com/news/nkgen-biotech-administers-first-dose-203000889.html
0 · Reply
DENNISF1
DENNISF1 Jul. 10 at 8:37 PM
$NKGN Fully loaded!!! All in and waiting on #GREATNEWS!!!!
2 · Reply
darkreef333
darkreef333 Jul. 10 at 4:32 AM
$NKGN $GTCH $NCNA $EDGM
0 · Reply
BCINU
BCINU Jul. 9 at 3:37 AM
$NKGN if this company has a chance it can easily get back to $5 +
0 · Reply
junglezoo
junglezoo Jul. 6 at 3:41 PM
$NKGN $VIGL
0 · Reply
Abdullah5566
Abdullah5566 Jul. 4 at 1:40 PM
@junglezoo is $NKGN planning to go back to Nasdaq ? will they need to request order ? what is the procedures?
1 · Reply
DENNISF1
DENNISF1 Jul. 3 at 3:23 PM
$NKGN
0 · Reply
DENNISF1
DENNISF1 Jul. 3 at 3:22 PM
$NKGN News for July 3, 2025 (Patience is life changing). NKGen Biotech (NKGN) Latest News (as of July 3, 2025): NKGen Biotech has activated two additional clinical trial sites in Canada and Florida for its Phase 1/2a trial of troculeucel, a cell therapy for moderate Alzheimer's disease. This expansion aims to enhance patient access and accelerate study recruitment. In May 2025, NKGen Biotech's Chairman and CEO, Dr. Paul Y. Song, made a personal investment of $2.65 million in the company. This investment is intended to support the acceleration of the Phase 2 clinical trial for Alzheimer's Disease and address financial obligations.
0 · Reply
Gj64
Gj64 Jul. 2 at 3:46 PM
$NKGN GRTX Yea baby yea!
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Jul. 2 at 1:21 AM
$NKGN hopefully good news soon !
0 · Reply
Latest News on NKGN
No data available.
RupertDCat
RupertDCat Jul. 11 at 2:29 AM
$NKGN https://finance.yahoo.com/news/nkgen-biotech-administers-first-dose-203000889.html
0 · Reply
DENNISF1
DENNISF1 Jul. 10 at 8:37 PM
$NKGN Fully loaded!!! All in and waiting on #GREATNEWS!!!!
2 · Reply
darkreef333
darkreef333 Jul. 10 at 4:32 AM
$NKGN $GTCH $NCNA $EDGM
0 · Reply
BCINU
BCINU Jul. 9 at 3:37 AM
$NKGN if this company has a chance it can easily get back to $5 +
0 · Reply
junglezoo
junglezoo Jul. 6 at 3:41 PM
$NKGN $VIGL
0 · Reply
Abdullah5566
Abdullah5566 Jul. 4 at 1:40 PM
@junglezoo is $NKGN planning to go back to Nasdaq ? will they need to request order ? what is the procedures?
1 · Reply
DENNISF1
DENNISF1 Jul. 3 at 3:23 PM
$NKGN
0 · Reply
DENNISF1
DENNISF1 Jul. 3 at 3:22 PM
$NKGN News for July 3, 2025 (Patience is life changing). NKGen Biotech (NKGN) Latest News (as of July 3, 2025): NKGen Biotech has activated two additional clinical trial sites in Canada and Florida for its Phase 1/2a trial of troculeucel, a cell therapy for moderate Alzheimer's disease. This expansion aims to enhance patient access and accelerate study recruitment. In May 2025, NKGen Biotech's Chairman and CEO, Dr. Paul Y. Song, made a personal investment of $2.65 million in the company. This investment is intended to support the acceleration of the Phase 2 clinical trial for Alzheimer's Disease and address financial obligations.
0 · Reply
Gj64
Gj64 Jul. 2 at 3:46 PM
$NKGN GRTX Yea baby yea!
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Jul. 2 at 1:21 AM
$NKGN hopefully good news soon !
0 · Reply
Gj64
Gj64 Jul. 1 at 7:19 PM
$NKGN https://www.nasdaq.com/market-activity/stocks/nkgn/insider-activity
0 · Reply
Gj64
Gj64 Jul. 1 at 4:44 PM
$NKGN GRTX
0 · Reply
BCINU
BCINU Jul. 1 at 2:45 PM
$NKGN keeps moving up hopefully good news is coming
0 · Reply
Gj64
Gj64 Jul. 1 at 2:45 PM
$NKGN https://brainfoundation.org/therapeutics-enterprise-ventures/nkgen-biotech/# GRTX
0 · Reply
darkreef333
darkreef333 Jul. 1 at 12:57 AM
$NKGN
0 · Reply
BCINU
BCINU Jun. 30 at 7:34 PM
$NKGN I like the volume lets go
0 · Reply
vu_jade
vu_jade Jun. 30 at 7:12 PM
$NKGN oh quid or quo no 20c
2 · Reply
DMAC1556
DMAC1556 Jun. 30 at 6:17 PM
$NKGN still buying.
0 · Reply
jParkz
jParkz Jun. 30 at 6:00 PM
News out Expected US Company Earnings on Monday, June 30th, 2025 https://marketwirenews.com/news-releases/expected-us-company-earnings-on-monday-june-30th-202-6267665274538923.html $NKGN
0 · Reply
BCINU
BCINU Jun. 30 at 4:23 PM
$NKGN there is much upside to this company. It is not going out of business and its future is positive
0 · Reply
Oilpatch1
Oilpatch1 Jun. 30 at 2:31 PM
$NKGN it's time for this to go up
0 · Reply
junglezoo
junglezoo Jun. 30 at 5:25 AM
$NKGN The market isn’t pricing in value, it’s pricing in uncertainty.
0 · Reply